Trial Profile
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary) ; PEG 3350
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Mar 2016 New trial record